临床病理指标 | n | CD44v6 | FN | |||||||||
− | + | ++ | 阳性(%) | − | + | ++ | 阳性(%) | |||||
性别 |
|
|
| |||||||||
男 | 90 | 49 | 20 | 21 | 41 (45.6) | 54 | 19 | 17 | 36 (40.0) | |||
女 | 50 | 31 | 9 | 10 | 19 (38.0) | 36 | 7 | 7 | 14 (28.0) | |||
年龄 |
|
|
|
|
|
|
|
|
| |||
≤40 | 51 | 30 | 10 | 11 | 21 (41.2) | 37 | 7 | 7 | 14 (27.5) | |||
>40 | 89 | 50 | 19 | 20 | 39 (43.8) | 53 | 19 | 17 | 36 (40.4) | |||
肉眼形态 |
|
|
|
|
|
|
|
|
| |||
巨块型 | 63 | 34 | 15 | 14 | 29 (46.0) | 39 | 10 | 14 | 24 (38.1) | |||
结节型 | 54 | 32 | 9 | 13 | 22 (40.7) | 36 | 11 | 7 | 18 (33.3) | |||
弥漫型 | 23 | 14 | 5 | 4 | 9 (39.1) | 15 | 5 | 3 | 8 (34.8) | |||
肿瘤大小 |
|
|
|
|
|
|
|
|
| |||
≤5 cm | 48 | 24 | 13 | 11 | 24 (50.0) | 34 | 8 | 6 | 14 (29.2) | |||
>5 cm | 92 | 56 | 16 | 20 | 36 (39.1) | 56 | 18 | 18 | 36 (39.1) | |||
分化程度 |
|
|
|
|
|
|
|
|
| |||
高分化 | 56 | 39 | 10 | 7 | 17 (30.4) | 28 | 9 | 19 | 28 (50.0) | |||
低分化 | 84 | 41 | 19 | 24 | 43 (48.8)* | 62 | 17 | 5 | 22 (26.2)* | |||
转移 |
|
|
|
|
|
|
|
|
| |||
无 | 77 | 54 | 14 | 9 | 23 (29.9) | 37 | 18 | 22 | 40 (51.9) | |||
有 | 63 | 26 | 15 | 22 | 37 (58.7)△ | 53 | 8 | 2 | 10 (15.9)△ | |||
随访满5年者 |
|
|
|
|
|
|
|
|
| |||
生存 | 22 | 13 | 6 | 3 | 9 (40.9) | 3 | 7 | 12 | 19 (86.4) | |||
死亡 | 62 | 20 | 18 | 24 | 42 (67.7)# | 39 | 13 | 10 | 23 (37.1)# | |||